SPOK

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced the entry into an agreement to sell certain narrowband spectrum licenses in its two-way paging inventory to Sensus USA, a designer and manufacturer of metering and automatic meter-reading products catering to municipal and industrial markets worldwide. The purchase price is $8 million, with a portion of the consideration deferred until existing Spok users have been mi.

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Spok Holdings, Inc. (NASDAQ: SPOK). The investigation focuses on Spok's executive officers and whether investor losses may be recovered under federal securities laws.

Spok Holdings, Inc. (SPOK) Q1 2026 Earnings Call Transcript

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the first quarter ended March 31, 2026. In addition, the Company's Board of Directors declared a regular quarterly dividend of $0.3125 per share, payable on June 24, 2026, to stockholders of record on May 26, 2026. Recent Highlights: Spok recently announced a strategic realignment designed to further reduce operating expenses and deliver in excess of $6.0.

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced it will release its first quarter 2026 operating results on Wednesday, April 29, 2026, after the close of the U.S. financial markets. Management will host a conference call and webcast to discuss these financial results on Wednesday, April 29, 2026, at 5:00 p.m. ET. The presentation is open to all interested parties and may include forward-looking information. Confere.

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced a strategic realignment designed to reduce costs and sharpen operational focus across its go-to-market functions. These actions will enable the Company to direct resources toward continued investment in its Care Connect Suite and artificial intelligence initiatives, while sustaining its commitment to returning cash to stockholders. “After extensive analysis by our man.